Molecule Signs a Letter of Intent with la Société Québécoise du Cannabis (SQDC)
Molecule Signs a Letter of Intent with la Société Québécoise du Cannabis (SQDC) |
[03-December-2020] |
OTTAWA, ON, Dec. 3, 2020 /CNW/ - Molecule Holdings Inc. (CSE: MLCL) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, has the pleasure of announcing that it has received authorization from l'Autorité des Marchés Publics (AMP) which enables the company to potentially obtain contracts with public entities in Québec. The company is also pleased to announce that it has signed a letter of intent with la Société Québécoise du Cannabis ("SQDC"), the public entity which governs all sales and distribution of cannabis in the province. Having received the authorization from the AMP in November, Molecule will be capable of commercializing its products in Québec, pending receipt of its sales license amendment from Health Canada. This authorization is valid for a duration of three (3) years and can be extended at the end of this term. "The AMP authorization is a huge milestone for Molecule," said Molecule's CEO, Phil Waddington. "This approval gives us the ability to strengthen our relationship with the SQDC and offer this broader market access to some of our valued clients." Letter of Intent with SQDC Molecule is also pleased to announce the signing of a letter of intent with the Société québécoise du cannabis, which was concluded in conjunction with Biolux Natural Health Inc. for the production and province-wide sales of UbU Blackberry & Juniper Berry sparkling CBD beverage as well as Citrus & Ginger sparkling CBD beverage. "As a Québec-based cannabis beverage company, we are very proud to have our home province as one of the first markets to launch the UbU beverage line. We strongly believe our low calorie, clean-label formulation and our unique flavours will appeal to Québec consumers," said Biolux President, Carlos Ponce. Philip Waddington, President & CEO of Molecule Inc., stated "This letter of intention with the SQDC is an important component of our volume projections and forward planning for 2021. This is another step forward in our mission to deliver craft-quality beverages to discerning consumers." ON BEHALF OF THE BOARD MOLECULE HOLDINGS INC. Per: "Philip Waddington" President, CEO and Director About Molecule Holdings Inc. About Biolux Natural Health Inc. Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this press release. Forward-Looking Statements SOURCE Molecule Holdings Inc. | ||
Company Codes: CNSX:MLCL |
© 2020 PR Newswire. All Rights Reserved.